跳至主要内容
临床试验/JPRN-jRCT1080225043
JPRN-jRCT1080225043已完成Unknown

Searching study for comparative examination in Forteo and Teribone in an osteoporosis patient after menopause

Kamagaya General Hospital0 个研究点目标入组 100 人开始时间: 2020年1月29日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
Female

入选标准

  • 1)Osteoporosis patient after menopause,who comes under more than the following one of 1 items
  • 1.Bone density; -2.5SD or less and Vulnerable fracture
  • 2.Lumbar spine bone density;Less than -3.3SD
  • 3.Existing vertebral fracture;More than 2
  • 4.Semi-quantitative evaluation method results(Existing vertebral fracture) is Grade3
  • 5.fracture of femur in the past
  • 3)The patient by whom own injection is possible

排除标准

  • 1)Hypercalcemia
  • 2)Risk of osteosarcoma occurrence is high
  • 3)Primary malignant bone tumor or Metastatic bone tumor
  • 4)Metabolic bone disease without osteoporosis
  • 5)Hypersensitivity for teriparatide
  • 6)A doctor in attendance is the patient who judged that participation in this research was unsuitable

研究者

相似试验

Forteo vs Teribone | 临床试验